Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0M7VW
|
||||
| Former ID |
DIB007633
|
||||
| Drug Name |
GR-65630
|
||||
| Synonyms |
GR-65630A
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Emesis [ICD9: 787; ICD10:R11] | Terminated | [1] | ||
| Company |
Glaxo Group Research Ltd
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H17N3O
|
||||
| Canonical SMILES |
c1(cn(c2c1cccc2)C)C(=O)CCc1nc[nH]c1C
|
||||
| CAS Number |
CAS 113140-33-3
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-Hydroxytryptamine 3 receptor | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003534) | ||||
| REF 2 | Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur J Pharmacol. 1989 Jan 10;159(2):157-64. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.